Severe retinopathy following radiation therapy with a moderate dose for orbital mucosa-associated lymphoid tissue lymphoma

Hematol Oncol. 2014 Dec;32(4):212-4. doi: 10.1002/hon.2124. Epub 2014 Jan 2.

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is a radiosensitive malignancy. We report on a case of severe retinopathy following radiation therapy with a moderate dose for orbital MALT lymphoma. A 69-year-old woman with orbital MALT lymphoma received definitive radiation therapy with a total dose of 36 Gy in 18 fractions. The patient showed complete response but had severe retinopathy along with marked deterioration in visual acuity at 2 years after irradiation. Although the patient underwent treatments for retinopathy, including laser photocoagulation and steroid injection, improvement of the visual acuity was modest. This case developed severe radiation-induced retinopathy after radiation therapy with the moderate dose of 36 Gy that is considered to be usually safe.

Keywords: mucosa-associated lymphoid tissue lymphoma; orbital lymphoma; radiation therapy; retinopathy; visual acuity.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Fundus Oculi
  • Humans
  • Lasers
  • Light Coagulation
  • Lymphoma, B-Cell, Marginal Zone / radiotherapy*
  • Mucous Membrane / radiation effects
  • Orbit / radiation effects
  • Orbital Neoplasms / radiotherapy*
  • Radiation Injuries / etiology*
  • Radiotherapy / adverse effects*
  • Retina / radiation effects*
  • Retinal Diseases / etiology*
  • Steroids / chemistry
  • Treatment Outcome

Substances

  • Steroids